The result, presented at the American Heart Association (AHA) Scientific Sessions 2025 over the weekend, means that the CORALreef Lipids trial met its primary endpoint
Naunyn-Schmiedeberg's Arch Pharmacol 396 , 13611370 (2023)
BPC-157 (Body Protection Compound-157) is a synthetic, stable pentadecapeptide of 15 amino acids derived from a partial sequence of a protein identified in gastric juice
DOI:10.1021/acs.oprd.5b00081
This effect on gastric emptying, coupled with its action on GLP-1R in the hypothalamusan area of the brain that regulates hunger and satietyresults in reduced food intake, making GLP-1 an important factor in weight management and obesity treatment [44,45]
Potential benefits of tirzepatide is superior blood sugar control, better weight management and minimized cardiovascular risk